Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
---|
02/27/1991 | EP0414078A2 Disubstituted (quinolin-2-yl-methoxy)-phenylacetic acid derivatives |
02/27/1991 | EP0414023A2 Pyrroloquinoline compounds |
02/27/1991 | EP0414018A2 Process for the preparation of dehydrocycloclausenamide and its derivatives in the racemic form and as optically active (+)- or (-)-enantiomers |
02/27/1991 | EP0413929A2 Use of an ace-inhibitor to treat or prevent depression |
02/27/1991 | EP0413794A1 Periodontal and bone regeneration factor, materials and methods |
02/27/1991 | EP0413762A1 Peptide analogs and their use as haptens to elicit catalytic antibodies |
02/27/1991 | EP0413750A1 Renin inhibitory peptides containing a substituted phenoxyacetyle group |
02/27/1991 | EP0413700A1 New alkylphosphono- and phosphoserines, method for preparing them, and pharmaceutical substances containing them |
02/27/1991 | CN1049505A Peptides having bradykinin-antagonistic action |
02/27/1991 | CN1049502A Process of preparing antiviral compound |
02/27/1991 | CN1049499A 2,3-dihydro-5-oxy-4,6,7-trimethylbenzofurans 2-(rs)- derivatives with properties of mucus-adjustment and antiischemia |
02/26/1991 | US4996358 Control, prevention rheumatic diseases |
02/26/1991 | US4996329 Derivatives of 1,4-dideoxy-1,4-imino-D-mannitol and a process for their preparation |
02/26/1991 | US4996318 Amino-9,10-secosteroids useful for treating head injury, spinal cord trauma or stroke |
02/26/1991 | US4996235 3,4-diphenylbutanamines |
02/26/1991 | US4996214 Respiratory systyem disorders |
02/26/1991 | CA1280749C Phenothiazine compounds |
02/25/1991 | WO1991002716A2 Hydroxamic acid based collagenase inhibitors |
02/25/1991 | CA2064786A1 Hydroxamic acid based collagenase inhibitors |
02/25/1991 | CA2023776A1 Leukotriene synthesis-inhibiting disubstituted (quinolin-2-yl-methoxy) phenylacetic acid derivatives |
02/25/1991 | CA2023609A1 7-keto or hydroxy 3,5-diene steroids as inhibitors of steroid 5--reductase |
02/24/1991 | WO1991002977A1 Wound healing preparations containing heparanase |
02/24/1991 | CA2065744A1 Wound healing preparations containing heparanase |
02/24/1991 | CA2023610A1 3-substituted nitro-steroid derivatives as 5-.alpha.-reductase inhibitors |
02/23/1991 | CA2023726A1 Pyrroloquinoline compounds |
02/22/1991 | CA2023157A1 17 beta-acyl-4-aza-5 alpha-androst-1-ene-3-ones as 5 alpha-reductase inhibitors |
02/22/1991 | CA2021409A1 Phosphonate substituted amino or imino acids useful as antihypertensives |
02/21/1991 | WO1991002342A1 Rotary display unit |
02/21/1991 | WO1991002063A1 Improvements in granulocyte-macrophage colony-stimulating factor receptor and derivatives thereof |
02/21/1991 | WO1991002058A1 Production of vascular endothelial cell growth factor |
02/21/1991 | WO1991001744A2 Uses of interleukin-4 and method for purifying it |
02/21/1991 | WO1991001727A2 Method of detection and treatment of malignant and non-malignant lesions by photochemotherapy |
02/21/1991 | WO1991001724A1 Renal-selective prodrugs for the treatment of hypertension |
02/21/1991 | WO1991001723A1 Process for disinfecting musculoskeletal tissue and tissues prepared thereby |
02/21/1991 | WO1991001639A1 Methods and compositions for ameliorating the symptoms of sepsis |
02/21/1991 | WO1991001624A2 Use of calcium antagonists for treating scars |
02/21/1991 | WO1991000281A3 Fused-ring aryl substituted imidazoles |
02/21/1991 | CA2064753A1 Uses of interleukin-4 and method for purifying it |
02/20/1991 | EP0413674A2 Phosphorylated glycosidase inhibitor prodrugs |
02/20/1991 | EP0413668A2 New 2,3-dihydro-5-oxy-4,6,7-trimethylbenzofuranes 2-(RS)-substitutes, useful as antioxidizing pharmaceutical products having mucoregolating and anti-ischemic properties |
02/20/1991 | EP0413544A2 Purine derivatives, process for their preparation, pharmaceutical compositions and intermediates |
02/20/1991 | EP0413383A1 Mutants of human interleukin-3 |
02/20/1991 | EP0413277A1 Peptide antagonists of bradykinin |
02/20/1991 | EP0413053A1 Process for producing useful substance from edible basidiomycete mycelium |
02/20/1991 | EP0413052A1 Process for producing Auricularia polytricha extract |
02/20/1991 | EP0413051A1 Benzothiazine-1,1-dioxide derivatives |
02/20/1991 | EP0412988A1 Fused polycyclic compounds, compositions, methods of manufacture and their use as paf antagonists, antihistamines and/or antiinflammatory agents |
02/20/1991 | CN1049353A Cyclic neurokinin a antagonists |
02/20/1991 | CN1049348A 2-oxa-1-oxo-8-azaspiro (4,5) decane derivatives, pharmaceutical compositions containing them and process for preparing same |
02/20/1991 | CN1049347A 2-oxa-1-oxo-8-azaspiro ¾4,5 decane derivatives, pharmaceutical compositions containing them and process for preparing same |
02/20/1991 | CN1049337A Thiazole derivatives, processes for production thereof and pharmaceutical compositions comprising same |
02/19/1991 | WO1991002737A1 Methylenediphosphonic acid compound and anti-inflammatory containing the same as active ingredient |
02/19/1991 | US4994582 Novel antibiotic NK130119 |
02/19/1991 | US4994556 Antitumor agents |
02/19/1991 | US4994457 Piroxicam, 5'-guanylic acid, and(or) N-acetyl-L-methionine |
02/19/1991 | CA2037932A1 Methylenediphosphonic acid compound and anti-inflammatory agent containing the compound as effective component |
02/19/1991 | CA2023522A1 2,3-dihydro-5-oxy-4,6,7-trimethylbenzofuranes 2-(rs)-substitutes, useful as antioxidizing pharmaceutical products having mucoregulating and anti-ischemic properties |
02/19/1991 | CA1280421C 1,4-disubstituted piperidinyl derivatives |
02/19/1991 | CA1280370C PHARMACEUTICAL AND DIETARY COMPOSITION CONTAINING .alpha.-LINOLEIC ACID |
02/18/1991 | CA2023291A1 Compounds |
02/17/1991 | CA2020700A1 Compositions for the inhibition of protein hormone formation and uses thereof |
02/13/1991 | EP0412939A2 Certain benzopyran and benzothiopyran derivatives |
02/13/1991 | EP0412820A2 2-Oxo-1-oxa-8-azaspiro[4,5] decane derivatives, processes for their preparation and pharmaceutical compositions thereof |
02/13/1991 | EP0412594A2 Substituted triazolinones, triazolinethiones, and triazolinimines as angiotensin II antagonists |
02/13/1991 | EP0412542A2 Cyclic neurokinin antagonists |
02/13/1991 | EP0412404A2 Thiazole derivatives, processes for production thereof and pharmaceutical compositions comprising the same |
02/13/1991 | EP0412350A2 Renininhibitors, procedure for their preparation and use as medicaments |
02/13/1991 | CN1049165A N-substituted cycloalkyl and polycycloalkyl alpha-substituted trp-phe and phenethylamine derivatives |
02/13/1991 | CN1049162A Dopamine agonists |
02/13/1991 | CN1049156A Indenoindole compounds i |
02/13/1991 | CN1049106A Stabilized fgf composition and production thereof |
02/13/1991 | CN1011571B Method of preparing for curing tumors |
02/12/1991 | US4992469 Method of obtaining an antiplatelet effect |
02/12/1991 | US4992462 Inhibitor of HMG-CoA reductase |
02/12/1991 | US4992444 Antitumor agents, skin disorders |
02/12/1991 | US4992430 Anti-bacterial compositions comprising a substituted bis-(4-aminophenyl)-sulfone and a dihydro-folic acid reductase |
02/12/1991 | US4992369 Fermentation process for glycopeptide antibiotic |
02/12/1991 | US4992271 Formulation for lipophilic IL-2 proteins |
02/12/1991 | CA2023016A1 Certain benzopyran and benzothiopyran derivatives |
02/11/1991 | CA2022842A1 Use of prophenytoin for treating stroke |
02/08/1991 | CA2022731A1 Thiazole derivatives, processes for production thereof and pharmaceutical compositions comprising the same |
02/07/1991 | WO1991001327A1 Peptides containing diamino-glycols as transition-state mimics |
02/07/1991 | WO1991001141A1 MODIFIED TRANSFORMING GROWTH FACTOR α OLIGOPEPTIDES AND PHARMACEUTICAL COMPOSITIONS THEREOF |
02/07/1991 | WO1991001137A1 Antiviral composition |
02/07/1991 | WO1991001133A1 T cell receptor peptides as therapeutics for autoimmune and malignant disease |
02/06/1991 | EP0411935A2 Copper radio sensitizers |
02/06/1991 | EP0411908A1 Imidazole compounds and their use as transglutaminase inhibitors |
02/06/1991 | EP0411754A2 Medicament for the inhibition of interleukin-1 or tumor necrosis factor production by monocytes and/or macrophages |
02/06/1991 | EP0411751A1 Renin inhibitory peptides |
02/06/1991 | EP0411705A1 Imidazole compounds and their use as transglutaminase inhibitors |
02/06/1991 | EP0411701A2 Certain imidazole compounds as transglutaminase inhibitors |
02/06/1991 | EP0411631A1 Anti-psychotic compounds |
02/06/1991 | EP0411096A1 Dna sequences coding for pth variants, pth variants, expression vector, bacterial host, use and therapeutic composition |
02/06/1991 | CA2022692A1 Renin inhibitors |
02/05/1991 | US4990538 Administering for the treatment of cancer |
02/05/1991 | US4990534 Aralkyl esters and processes for their preparation |
02/05/1991 | US4990518 Pharmacologically active heteroaryl substituted imidazo (4,5-c) pyridines |
02/05/1991 | CA1279872C Cycloalkyl diphosphonic acid compounds and pharmaceutically-acceptable salts and esters thereof |
02/04/1991 | CA2021926A1 Heterocyclic compounds |
02/02/1991 | CA2022311A1 Copper radiosensitizers |